Published in Cancer Lett on January 29, 2013
Apoptotic effects of high-dose rapamycin occur in S-phase of the cell cycle. Cell Cycle (2015) 1.01
Rapamycin-induced G1 cell cycle arrest employs both TGF-β and Rb pathways. Cancer Lett (2015) 0.96
mTOR inhibitors induce apoptosis in colon cancer cells via CHOP-dependent DR5 induction on 4E-BP1 dephosphorylation. Oncogene (2015) 0.95
Mutant ras elevates dependence on serum lipids and creates a synthetic lethality for rapamycin. Mol Cancer Ther (2014) 0.85
Reciprocal regulation of AMP-activated protein kinase and phospholipase D. J Biol Chem (2015) 0.80
Differential Proteome Analysis Identifies TGF-β-Related Pro-Metastatic Proteins in a 4T1 Murine Breast Cancer Model. PLoS One (2015) 0.79
Erythroid induction of K562 cells treated with mithramycin is associated with inhibition of raptor gene transcription and mammalian target of rapamycin complex 1 (mTORC1) functions. Pharmacol Res (2014) 0.77
Transforming growth factor-β: an important mediator in Helicobacter pylori-associated pathogenesis. Front Cell Infect Microbiol (2015) 0.77
The Enigma of Rapamycin Dosage. Mol Cancer Ther (2016) 0.76
Hallmarks of cancer: the next generation. Cell (2011) 140.01
Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes. Nature (1983) 19.76
mTOR inhibition induces upstream receptor tyrosine kinase signaling and activates Akt. Cancer Res (2006) 18.44
Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt/PKB. Mol Cell (2006) 18.36
TGFbeta in Cancer. Cell (2008) 17.44
Activation of Akt and eIF4E survival pathways by rapamycin-mediated mammalian target of rapamycin inhibition. Cancer Res (2005) 7.34
Regulation of cap-dependent translation by eIF4E inhibitory proteins. Nature (2005) 6.69
Antitumor activity of rapamycin in a Phase I trial for patients with recurrent PTEN-deficient glioblastoma. PLoS Med (2008) 5.54
mTOR controls cell cycle progression through its cell growth effectors S6K1 and 4E-BP1/eukaryotic translation initiation factor 4E. Mol Cell Biol (2004) 5.46
Hierarchical phosphorylation of the translation inhibitor 4E-BP1. Genes Dev (2001) 5.37
Dose- and schedule-dependent inhibition of the mammalian target of rapamycin pathway with everolimus: a phase I tumor pharmacodynamic study in patients with advanced solid tumors. J Clin Oncol (2008) 5.28
mTORC1-mediated cell proliferation, but not cell growth, controlled by the 4E-BPs. Science (2010) 4.81
Genetic dissection of the oncogenic mTOR pathway reveals druggable addiction to translational control via 4EBP-eIF4E. Cancer Cell (2010) 3.79
p70S6 kinase signals cell survival as well as growth, inactivating the pro-apoptotic molecule BAD. Proc Natl Acad Sci U S A (2001) 3.11
Regulation of mTORC1 and mTORC2 complex assembly by phosphatidic acid: competition with rapamycin. Mol Cell Biol (2008) 2.85
Focus on pancreas cancer. Cancer Cell (2002) 2.82
Not all substrates are treated equally: implications for mTOR, rapamycin-resistance and cancer therapy. Cell Cycle (2009) 2.45
Phospholipase D confers rapamycin resistance in human breast cancer cells. Oncogene (2003) 2.13
Lost in translation: dysregulation of cap-dependent translation and cancer. Cancer Cell (2004) 1.91
Novel roles of Akt and mTOR in suppressing TGF-beta/ALK5-mediated Smad3 activation. EMBO J (2005) 1.85
S6K1-mediated disassembly of mitochondrial URI/PP1gamma complexes activates a negative feedback program that counters S6K1 survival signaling. Mol Cell (2007) 1.66
Alternative phospholipase D/mTOR survival signal in human breast cancer cells. Oncogene (2005) 1.58
Targeting the mTOR kinase domain: the second generation of mTOR inhibitors. Drug Discov Today (2011) 1.52
High-dose rapamycin induces apoptosis in human cancer cells by dissociating mTOR complex 1 and suppressing phosphorylation of 4E-BP1. Cell Cycle (2011) 1.44
A systematic review and meta-analysis of the relationship between chromosome 18q genotype, DCC status and colorectal cancer prognosis. Eur J Cancer (2005) 1.31
Defective TGF-beta signaling sensitizes human cancer cells to rapamycin. Oncogene (2007) 1.27
Smad3 and PKCdelta mediate TGF-beta1-induced collagen I expression in human mesangial cells. Am J Physiol Renal Physiol (2003) 1.22
S6K1 deficiency protects against apoptosis in hepatocytes. Hepatology (2009) 1.11
Therapeutic potential of target of rapamycin inhibitors. Expert Opin Ther Targets (2004) 1.10
Targeting renal cell carcinoma with NVP-BEZ235, a dual PI3K/mTOR inhibitor, in combination with sorafenib. Mol Cancer (2011) 1.07
Transforming growth factor-beta 1 regulates Kir2.3 inward rectifier K+ channels via phospholipase C and protein kinase C-delta in reactive astrocytes from adult rat brain. J Biol Chem (2001) 1.00
Suppression of TGF-beta signaling by phospholipase D. Cell Cycle (2007) 0.98
Suppression of cell migration by protein kinase Cdelta. Oncogene (2005) 0.94
Regulation of mTORC1 and mTORC2 complex assembly by phosphatidic acid: competition with rapamycin. Mol Cell Biol (2008) 2.85
Differential dependence of hypoxia-inducible factors 1 alpha and 2 alpha on mTORC1 and mTORC2. J Biol Chem (2008) 2.38
Phospholipase D confers rapamycin resistance in human breast cancer cells. Oncogene (2003) 2.13
The enigmatic protein kinase Cdelta: complex roles in cell proliferation and survival. FASEB J (2004) 1.85
Phospholipase D couples survival and migration signals in stress response of human cancer cells. J Biol Chem (2006) 1.78
The lymphocyte function-associated antigen-1 receptor costimulates plasma membrane Ras via phospholipase D2. Nat Cell Biol (2007) 1.72
Alternative phospholipase D/mTOR survival signal in human breast cancer cells. Oncogene (2005) 1.58
High-dose rapamycin induces apoptosis in human cancer cells by dissociating mTOR complex 1 and suppressing phosphorylation of 4E-BP1. Cell Cycle (2011) 1.44
Honokiol suppresses survival signals mediated by Ras-dependent phospholipase D activity in human cancer cells. Clin Cancer Res (2008) 1.43
Presenilin-1 uses phospholipase D1 as a negative regulator of beta-amyloid formation. Proc Natl Acad Sci U S A (2006) 1.41
Phospholipase D provides a survival signal in human cancer cells with activated H-Ras or K-Ras. Cancer Lett (2007) 1.31
Phospholipase D mediates nutrient input to mammalian target of rapamycin complex 1 (mTORC1). J Biol Chem (2011) 1.20
Phospholipase D prevents apoptosis in v-Src-transformed rat fibroblasts and MDA-MB-231 breast cancer cells. Biochem Biophys Res Commun (2003) 1.20
Suppression of hypoxia-inducible factor 2alpha restores p53 activity via Hdm2 and reverses chemoresistance of renal carcinoma cells. Cancer Res (2009) 1.18
Efficient synthesis and photodynamic activity of porphyrin-saccharide conjugates: targeting and incapacitating cancer cells. Biochemistry (2004) 1.16
Association of a clinical knowledge support system with improved patient safety, reduced complications and shorter length of stay among Medicare beneficiaries in acute care hospitals in the United States. Int J Med Inform (2008) 1.15
Amino acids and mTOR mediate distinct metabolic checkpoints in mammalian G1 cell cycle. PLoS One (2013) 1.15
Phospholipase D1 corrects impaired betaAPP trafficking and neurite outgrowth in familial Alzheimer's disease-linked presenilin-1 mutant neurons. Proc Natl Acad Sci U S A (2006) 1.14
Survival signals generated by estrogen and phospholipase D in MCF-7 breast cancer cells are dependent on Myc. Mol Cell Biol (2005) 1.12
Elevated phospholipase D activity in H-Ras- but not K-Ras-transformed cells by the synergistic action of RalA and ARF6. Mol Cell Biol (2003) 1.07
mTOR-dependent suppression of protein phosphatase 2A is critical for phospholipase D survival signals in human breast cancer cells. J Biol Chem (2005) 1.03
Apoptotic effects of high-dose rapamycin occur in S-phase of the cell cycle. Cell Cycle (2015) 1.01
Myc stabilization in response to estrogen and phospholipase D in MCF-7 breast cancer cells. FEBS Lett (2006) 0.98
Suppression of TGF-beta signaling by phospholipase D. Cell Cycle (2007) 0.98
Phospholipase D elevates the level of MDM2 and suppresses DNA damage-induced increases in p53. Mol Cell Biol (2004) 0.97
Suppression of AKT phosphorylation restores rapamycin-based synthetic lethality in SMAD4-defective pancreatic cancer cells. Mol Cancer Res (2013) 0.95
Phospholipase D-mTOR requirement for the Warburg effect in human cancer cells. Cancer Lett (2010) 0.95
Phospholipase D2 stimulates cell protrusion in v-Src-transformed cells. Biochem Biophys Res Commun (2002) 0.94
Phospholipase D overcomes cell cycle arrest induced by high-intensity Raf signaling. Oncogene (2002) 0.94
Suppression of cell migration by protein kinase Cdelta. Oncogene (2005) 0.94
Downregulating PKC delta provides a PI3K/Akt-independent survival signal that overcomes apoptotic signals generated by c-Src overexpression. Oncogene (2002) 0.94
Inhibition of human p53 basal transcription by down-regulation of protein kinase Cdelta. J Biol Chem (2003) 0.91
The association between hospital outcomes and diagnostic imaging: early findings. J Am Coll Radiol (2009) 0.86
Mutant ras elevates dependence on serum lipids and creates a synthetic lethality for rapamycin. Mol Cancer Ther (2014) 0.85
Elevated phospholipase D activity induces apoptosis in normal rat fibroblasts. Biochem Biophys Res Commun (2002) 0.81
A chemodosimeter approach to fluorescent sensing and imaging of inorganic and methylmercury species. Chem Commun (Camb) (2009) 0.81
Low concentrations of a non-hydrolysable tetra-S-glycosylated porphyrin and low light induces apoptosis in human breast cancer cells via stress of the endoplasmic reticulum. Photochem Photobiol Sci (2008) 0.80
Carcinogen-induced early molecular events and its implication in the initiation of chemical hepatocarcinogenesis in rats: chemopreventive role of vanadium on this process. Biochim Biophys Acta (2006) 0.79
Is anybody managing the store? National trends in hospital performance. J Healthc Manag (2006) 0.79
Molecular basis of anticlastogenic potential of vanadium in vivo during the early stages of diethylnitrosamine-induced hepatocarcinogenesis in rats. Mutat Res (2006) 0.78
Reaction-based fluorescent sensing of Au(I)/Au(III) species: mechanistic implications on vinylgold intermediates. Org Lett (2010) 0.78
Cost and effectiveness of glycoprotein IIb/IIIa-receptor inhibitors in patients with acute myocardial infarction undergoing percutaneous coronary intervention. Am J Health Syst Pharm (2003) 0.77
Vanadium limits the expression of proliferating cell nuclear antigen and inhibits early DNA damage during diethylnitrosamine-induced hepatocellular preneoplasia in rats. Environ Mol Mutagen (2006) 0.77
Molecular basis of vanadium-mediated inhibition of hepatocellular preneoplasia during experimental hepatocarcinogenesis in rats. J Cell Biochem (2007) 0.76
Chemopreventive effect of vanadium in a rodent model of chemical hepatocarcinogenesis: reflections in oxidative DNA damage, energy-dispersive X-ray fluorescence profile and metallothionein expression. J Biol Inorg Chem (2006) 0.76
Vanadium inhibits the development of 2-acetylaminofluorene-induced premalignant phenotype in a two-stage chemical rat hepatocarcinogenesis model. Life Sci (2005) 0.76
Cell proliferation and hepatocarcinogenesis in rat initiated by diethylnitrosamine and promoted by phenobarbital: potential roles of early DNA damage and liver metallothionein expression. Life Sci (2007) 0.76
Kawasaki syndrome hospitalizations and associated costs in the United States. Public Health Rep (2003) 0.76
Phospholipase D stabilizes HDM2 through an mTORC2/SGK1 pathway. Biochem Biophys Res Commun (2010) 0.76
Garcinia benzophenones inhibit the growth of human colon cancer cells and synergize with sulindac sulfide and turmeric. Anticancer Agents Med Chem (2013) 0.75
Cardiac revascularization in specialty and general hospitals. N Engl J Med (2005) 0.75
Mesoporous TiO2 nanoparticles containing Ag ion with excellent antimicrobial activity at remarkable low silver concentrations. J Biomed Nanotechnol (2013) 0.75
An AIE-based Chemodosimeter Approach for Selective Sensing and Imaging of Hg(II) and Methylmercury Species. Anal Chem (2017) 0.75
A reaction based turn-on type fluorogenic and chromogenic probe for the detection of trace amount of nitrite in water. Talanta (2012) 0.75
Obituary: Hidesaburo Hanafusa (1929-2009). Nature (2009) 0.75